SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 8 filers reported holding SEATTLE GENETICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $702,216 | +32.7% | 3,310 | +20.4% | 0.04% | +37.9% |
Q2 2023 | $529,265 | -4.9% | 2,750 | 0.0% | 0.03% | -12.1% |
Q1 2023 | $556,792 | +57.6% | 2,750 | 0.0% | 0.03% | +50.0% |
Q4 2022 | $353,402 | -6.0% | 2,750 | 0.0% | 0.02% | -15.4% |
Q3 2022 | $376,000 | -22.8% | 2,750 | 0.0% | 0.03% | -18.8% |
Q2 2022 | $487,000 | +23.0% | 2,750 | 0.0% | 0.03% | +45.5% |
Q1 2022 | $396,000 | -6.8% | 2,750 | 0.0% | 0.02% | +4.8% |
Q4 2021 | $425,000 | -9.0% | 2,750 | 0.0% | 0.02% | -19.2% |
Q3 2021 | $467,000 | +64.4% | 2,750 | +52.8% | 0.03% | +62.5% |
Q2 2021 | $284,000 | +13.6% | 1,800 | 0.0% | 0.02% | +6.7% |
Q1 2021 | $250,000 | -20.6% | 1,800 | 0.0% | 0.02% | -25.0% |
Q4 2020 | $315,000 | +21.6% | 1,800 | +35.8% | 0.02% | +5.3% |
Q3 2020 | $259,000 | +13.1% | 1,325 | -1.5% | 0.02% | +5.6% |
Q2 2020 | $229,000 | – | 1,345 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |